2026年全球就地檢驗市場報告

近年來，新生兒就地檢驗市場發展迅速，預計將從2025年的13.2億美元成長到2026年的15.2億美元，複合年成長率達14.5%。過去幾年的成長可歸因於多種因素，例如人們對新生兒死亡率的認知不斷提高、醫院引入快速檢測設備、政府對新生兒護理的支持、產科診所的擴張以及床邊檢測技術的進步。

預計未來幾年，新生兒就地檢驗市場規模將快速成長，到2030年將達到25.9億美元，複合年成長率（CAGR）為14.3%。預測期內的成長可歸因於人工智慧診斷解決方案的興起、新生兒資料管理的雲端整合、攜帶式小型照護現場設備的普及、新生兒護理領域公私合營的增加以及新興經濟體新生兒醫療保健基礎設施的不斷完善。預測期內的關鍵趨勢包括：基於人工智慧的新生兒診斷、基於雲端的照護現場平台、攜帶式檢測設備、即時數據分析以及用於新生兒監測的物聯網整合。

預計未來幾年，對遠端患者監護日益成長的需求將推動新生兒就地檢驗市場的發展。遠端患者監護透過連接患者和醫療專業人員的技術提供醫療保健服務。尤其對於偏遠和醫療服務不足地區的患者而言，對便利醫療保健的需求不斷成長，推動了對遠端患者監護的需求。新生兒就地檢驗透過提供快速的床邊診斷結果來支援遠端患者監護，使醫療專業人員能夠快速檢測和處理新生兒的嚴重，而無需依賴中心檢查室。例如，根據美國醫療科技公司Vivalink在2023年8月進行的一項調查，84%的現有遠距病患監測（RPM）使用者計畫在2024年擴大其使用範圍，45%的醫療機構正在將RPM應用於家庭醫院計畫的急性監護。此外，77%的受訪者預測，基於RPM的照護將在未來五年內超越傳統的住院照護。因此，對遠端患者監護日益成長的需求預計將推動新生兒就地檢驗市場的發展。

新生兒就地檢驗市場的主要企業正在建立策略聯盟，旨在擴大診斷的可及性並改善新生兒的早期護理。策略聯盟是指各組織為了實現通用目標而整合資源和專業知識的夥伴關係。例如，2025年1月，總部位於荷蘭的樣本和檢測技術供應商QIAGEN與英國基因組學機構Genomics England建立了合作關係。此次合作將支持「世代研究」（Generation Study）的推出，計劃旨在對英國10萬名新生兒的基因組進行定序，並識別200多種可治療的遺傳疾病。 QIAGEN將為照護現場定序中評估的基因提供具有臨床意義的遺傳變異數據，從而加快分析和報告結果的速度。研究計畫於2024年10月正式啟動，預計將改善英國每年約3,000名新生兒所患疾病的早期檢測和治療。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球新生兒就地檢驗市場：吸引力評分與分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 人工智慧（AI）和自主人工智慧
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 物聯網、智慧基礎設施和互聯生態系統
• 主要趨勢
  • 基於人工智慧的新生兒診斷
  • 基於雲端的即時護理平台
  • 攜帶式檢測裝置
  • 即時數據分析
  • 物聯網在新生兒監護的應用

第5章 終端用戶產業市場分析

• 醫院
• 診斷中心
• 婦產科診所
• 專科診所
• 研究所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球新生兒就地檢驗市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球新生兒就地檢驗市場規模、對比及成長率分析
• 全球新生兒就地檢驗市場表現：規模與成長，2020-2025年
• 全球新生兒就地檢驗市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 依產品
• 設備、檢測
• 按測試類型
• 新生兒膽紅素檢測、血糖檢測、傳染病篩檢、電解質檢測及其他檢測項目
• 最終用戶
• 醫院、婦產科和專科診所及其他最終用戶
• 按類型細分：設備
• 血液氣體分析儀、膽紅素測量儀、血糖測量儀
• 按類型細分：偵測
• 膽紅素測定、葡萄糖測定、感染疾病測定、電解質測定、血氣測定

第10章 區域與國家分析

• 全球新生兒就地檢驗市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
• 全球新生兒就地檢驗市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 新生兒就地檢驗市場：競爭格局及市場佔有率（2024年）
• 新生兒就地檢驗市場：公司估值矩陣
• 新生兒就地檢驗市場：公司概況
  • Abbott Laboratories
  • Siemens Healthineers AG
  • GE Healthcare Technologies Inc.
  • Koninklijke Philips NV
  • Roche Diagnostics International AG

第37章：其他領先和創新企業

• Danaher Corporation, Drager AG & Co. KGaA, Masimo Corporation, Radiometer Medical ApS, Nova Biomedical Corporation, bioMerieux SA, Sysmex Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Contec Medical Systems Co. Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix Srl, GINEVRI Srl

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年新生兒就地檢驗市場：提供新機會的國家
• 2030年新生兒就地檢驗市場：充滿新機會的細分市場
• 2030年新生兒就地檢驗市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Neonatal point-of-care testing is the practice of performing diagnostic evaluations near the location where newborns receive care. It provides immediate clinical information, enabling rapid and informed decision-making. This approach delivers timely and accurate results while reducing the delays and logistical challenges associated with traditional laboratory testing.

The primary products in neonatal point-of-care testing include instruments and assays. Instruments consist of portable analyzers, handheld readers, and bedside monitors used to assess newborn health directly in care settings. Test types include neonatal bilirubin testing, newborn metabolic screening, blood glucose testing, infectious disease screening, electrolyte testing, and others. Key end-users include hospitals, diagnostic centers, maternity and specialty clinics, and additional healthcare facilities.

Tariffs are impacting the neonatal point of care testing market by increasing the cost of imported instruments, reagents, and kits. This has slowed adoption in hospitals and maternity clinics in regions such as Asia-Pacific and Europe. Instruments like blood gas analyzers and bilirubinometers are most impacted. Positive impacts include encouragement of local manufacturing and domestic reagent production, which improves supply chain resilience and lowers long-term operational costs.

The neonatal point of care testing market research report is one of a series of new reports from The Business Research Company that provides neonatal point of care testing market statistics, including neonatal point of care testing industry global market size, regional shares, competitors with a neonatal point of care testing market share, detailed neonatal point of care testing market segments, market trends and opportunities, and any further data you may need to thrive in the neonatal point of care testing industry. This neonatal point of care testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neonatal point of care testing market size has grown rapidly in recent years. It will grow from $1.32 billion in 2025 to $1.52 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing neonatal mortality awareness, adoption of rapid testing devices in hospitals, government support for neonatal care, expansion of maternity clinics, technological improvements in bedside testing.

The neonatal point of care testing market size is expected to see rapid growth in the next few years. It will grow to $2.59 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to rise of AI-based diagnostic solutions, cloud integration for neonatal data management, portable and compact point-of-care devices, increasing private-public partnerships in newborn health, growth in emerging economies' neonatal healthcare infrastructure. Major trends in the forecast period include AI-enabled neonatal diagnostics, cloud-based point-of-care platforms, portable testing devices, real-time data analysis, integration of IoT for newborn monitoring.

The rising demand for remote patient monitoring is anticipated to drive the growth of the neonatal point-of-care testing market in the coming years. Remote patient monitoring involves delivering healthcare services through technology that connects patients and healthcare professionals remotely. The increasing demand for remote patient monitoring is driven by the growing need for accessible and convenient healthcare, particularly for patients in remote or underserved regions. Neonatal point-of-care testing supports remote patient monitoring by offering rapid bedside diagnostic results, enabling healthcare providers to promptly detect and manage critical conditions in newborns without dependence on centralized laboratories. For example, in August 2023, according to Vivalink, a US-based healthcare technology company, a recent survey found that 84% of existing remote patient monitoring (RPM) users plan to expand their use in 2024, 45% of healthcare providers are applying RPM for acute monitoring in hospital-at-home programs, and 77% believe RPM-based care will surpass traditional inpatient hospital care within the next five years. Consequently, the growing demand for remote patient monitoring is expected to fuel the growth of the neonatal point-of-care testing market.

Leading companies in the neonatal point of care testing market are forming strategic collaborations to expand access to diagnostics and improve early healthcare for newborns. Strategic collaborations involve partnerships between organizations that combine their resources and expertise to reach shared objectives. For example, in January 2025, QIAGEN, a provider of sample and assay technologies based in the Netherlands, entered a partnership with Genomics England, a genomic medicine organization located in the United Kingdom. This collaboration supported the launch of the Generation Study, a project aimed at sequencing the genomes of one hundred thousand newborns in England to identify more than two hundred treatable genetic conditions. QIAGEN is contributing clinically relevant genetic variant data for the genes assessed in the point of care sequencing test, enabling faster analysis and reporting of results. The study officially began in October 2024 and is expected to impact the early detection and treatment of conditions affecting approximately three thousand newborns each year in the United Kingdom.

In March 2025, LaCAR MDx Technologies, a biotechnology company based in Belgium, acquired the newborn screening division of Baebies Incorporated for an undisclosed amount. This acquisition expands LaCAR's portfolio by increasing the range of neonatal diagnostic solutions it can offer and supports the company's growth in the United States market. Baebies Incorporated is a company based in the United States that specializes in neonatal point of care testing.

Major companies operating in the neonatal point of care testing market are Abbott Laboratories, Siemens Healthineers AG, GE Healthcare Technologies Inc., Koninklijke Philips N.V., Roche Diagnostics International AG, Danaher Corporation, Drager AG & Co. KGaA, Masimo Corporation, Radiometer Medical ApS, Nova Biomedical Corporation, bioMerieux SA, Sysmex Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Contec Medical Systems Co. Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.l., GINEVRI Srl

North America was the largest region in the neonatal point of care testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal point of care testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neonatal point of care testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neonatal point of care testing market consists of revenues earned by entities by providing services such as rapid diagnostic screening, blood gas and electrolyte analysis, glucose level monitoring, and sepsis detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The neonatal point of care testing market also includes sales of portable diagnostic analyzers, oxygen saturation monitors, hematology analyzers, and lactate analyzers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neonatal Point Of Care Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses neonatal point of care testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neonatal point of care testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neonatal point of care testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Instruments; Assay
• 2) By Test Type: Neonatal Bilirubin Testing; Blood Glucose Testing; Infectious Disease Screening; Electrolyte Testing; Other Test Types
• 3) By End-Users: Hospitals; Maternity And Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Instruments: Blood Gas Analyzers; Bilirubinometers; Glucose Meters
• 2) By Assay: Bilirubin Assays; Glucose Assays; Infectious Disease Assays; Electrolyte Assays; Blood Gas Assays
• Companies Mentioned: Abbott Laboratories; Siemens Healthineers AG; GE Healthcare Technologies Inc.; Koninklijke Philips N.V.; Roche Diagnostics International AG; Danaher Corporation; Drager AG & Co. KGaA; Masimo Corporation; Radiometer Medical ApS; Nova Biomedical Corporation; bioMerieux SA; Sysmex Corporation; Nihon Kohden Corporation; Natus Medical Incorporated; Contec Medical Systems Co. Ltd.; Edan Instruments Inc.; Trivitron Healthcare; Bistos Co. Ltd.; Bilimetrix S.r.l.; GINEVRI Srl
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Neonatal Point Of Care Testing Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Neonatal Point Of Care Testing Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Neonatal Point Of Care Testing Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Neonatal Point Of Care Testing Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Ai-Enabled Neonatal Diagnostics
  • 4.2.2 Cloud-Based Point-Of-Care Platforms
  • 4.2.3 Portable Testing Devices
  • 4.2.4 Real-Time Data Analysis
  • 4.2.5 Integration Of Iot For Newborn Monitoring

5. Neonatal Point Of Care Testing Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Centers
• 5.3 Maternity Clinics
• 5.4 Specialty Clinics
• 5.5 Research Institutions

6. Neonatal Point Of Care Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neonatal Point Of Care Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Neonatal Point Of Care Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Neonatal Point Of Care Testing Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Neonatal Point Of Care Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Neonatal Point Of Care Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neonatal Point Of Care Testing Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neonatal Point Of Care Testing Market Segmentation

• 9.1. Global Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Instruments, Assay
• 9.2. Global Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Neonatal Bilirubin Testing, Blood Glucose Testing, Infectious Disease Screening, Electrolyte Testing, Other Test Types
• 9.3. Global Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Maternity And Specialty Clinics, Other End-Users
• 9.4. Global Neonatal Point Of Care Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Blood Gas Analyzers, Bilirubinometers, Glucose Meters
• 9.5. Global Neonatal Point Of Care Testing Market, Sub-Segmentation Of Assay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bilirubin Assays, Glucose Assays, Infectious Disease Assays, Electrolyte Assays, Blood Gas Assays

10. Neonatal Point Of Care Testing Market Regional And Country Analysis

• 10.1. Global Neonatal Point Of Care Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Neonatal Point Of Care Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neonatal Point Of Care Testing Market

• 11.1. Asia-Pacific Neonatal Point Of Care Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neonatal Point Of Care Testing Market

• 12.1. China Neonatal Point Of Care Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neonatal Point Of Care Testing Market

• 13.1. India Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neonatal Point Of Care Testing Market

• 14.1. Japan Neonatal Point Of Care Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neonatal Point Of Care Testing Market

• 15.1. Australia Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neonatal Point Of Care Testing Market

• 16.1. Indonesia Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neonatal Point Of Care Testing Market

• 17.1. South Korea Neonatal Point Of Care Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neonatal Point Of Care Testing Market

• 18.1. Taiwan Neonatal Point Of Care Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neonatal Point Of Care Testing Market

• 19.1. South East Asia Neonatal Point Of Care Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neonatal Point Of Care Testing Market

• 20.1. Western Europe Neonatal Point Of Care Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neonatal Point Of Care Testing Market

• 21.1. UK Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neonatal Point Of Care Testing Market

• 22.1. Germany Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neonatal Point Of Care Testing Market

• 23.1. France Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neonatal Point Of Care Testing Market

• 24.1. Italy Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neonatal Point Of Care Testing Market

• 25.1. Spain Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neonatal Point Of Care Testing Market

• 26.1. Eastern Europe Neonatal Point Of Care Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neonatal Point Of Care Testing Market

• 27.1. Russia Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neonatal Point Of Care Testing Market

• 28.1. North America Neonatal Point Of Care Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neonatal Point Of Care Testing Market

• 29.1. USA Neonatal Point Of Care Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neonatal Point Of Care Testing Market

• 30.1. Canada Neonatal Point Of Care Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neonatal Point Of Care Testing Market

• 31.1. South America Neonatal Point Of Care Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neonatal Point Of Care Testing Market

• 32.1. Brazil Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neonatal Point Of Care Testing Market

• 33.1. Middle East Neonatal Point Of Care Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neonatal Point Of Care Testing Market

• 34.1. Africa Neonatal Point Of Care Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Neonatal Point Of Care Testing Market, Segmentation By Product, Segmentation By Test Type, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neonatal Point Of Care Testing Market Regulatory and Investment Landscape

36. Neonatal Point Of Care Testing Market Competitive Landscape And Company Profiles

• 36.1. Neonatal Point Of Care Testing Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Neonatal Point Of Care Testing Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Neonatal Point Of Care Testing Market Company Profiles
  • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Roche Diagnostics International AG Overview, Products and Services, Strategy and Financial Analysis

37. Neonatal Point Of Care Testing Market Other Major And Innovative Companies

• Danaher Corporation, Drager AG & Co. KGaA, Masimo Corporation, Radiometer Medical ApS, Nova Biomedical Corporation, bioMerieux SA, Sysmex Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Contec Medical Systems Co. Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.l., GINEVRI Srl

38. Global Neonatal Point Of Care Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neonatal Point Of Care Testing Market

40. Neonatal Point Of Care Testing Market High Potential Countries, Segments and Strategies

• 40.1 Neonatal Point Of Care Testing Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Neonatal Point Of Care Testing Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Neonatal Point Of Care Testing Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer